Id Now Covid-19 2.0
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings. 510(k) K221925, from Abbott Diagnostics Scarborough, Inc. (Scarborough, ME). Product code QWR, class 2.
As of Nov 19, 2026, K221925 is an FDA 510(k) held by Abbott Diagnostics Scarborough, Inc., substantially equivalent on Aug 10, 2023 after 405 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 405 days
- Recalls: 2
- Cited as a predicate by: 2 devices
ID NOW COVID-19 2.0 performed on the ID NOW Instrument is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology (NAAT) intended for the qualitative detection of nucleic acid from SARS-CoV-2 in direct anterior nasal (nasal) or nasopharyngeal swabs from individuals with signs and symptoms of respiratory tract infection.
- Sofia 2 SARS Antigen+ FIA, Sofia 2 SARS Antigen+ FIA Control Swab SetDEN220039 · Quidel Corporation · Mar 8, 2023
- ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0K262747 · Abbott Diagnostics Scarborough, Inc. · Aug 31, 2026
- cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat SystemK223783 · Roche Molecular Systems, Inc. · Dec 4, 2023
| Mar 4, 2025 | Z-1574-2025the impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use. | Open |
| Mar 4, 2025 | Z-1571-2025The impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use. | Open |
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Jul 1, 2022
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3982
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files